NIH panel refutes FDA’s claims of the benefits of coronavirus plasma treatment
Convalescent plasma from a recovered coronavirus disease (COVID-19) patient is seen at the Central Seattle Donor Center of Bloodworks Northwest during the outbreak in Seattle, Washington, April 17, 2020.
Lindsey Wasson | Reuters
A panel of experts convened by the National Institutes of Health said Tuesday there is “insufficient data” to show convalescent plasma works against the coronavirus, refuting claims made by President Donald Trump and the head of the Food and Drug Administration.
The panel said it reviewed available data on the treatment and found nothing from “well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma” for the treatment of Covid-19. It also said “there was no difference in 7-day survival” for patients, contradicting FDA Commissioner Dr. Stephen Hahn, who said the treatment resulted in a 35% improvement in survival.
“There are insufficient data to …continued .
[Source: CNBC News]